Advanced search
Publication Cover
Leukemia & Lymphoma Volume 55, 2014 - Issue 5
Submit an article Journal homepage
605
Views
6
CrossRef citations to date
0
Altmetric
Letter

Activity and toxicity profiles of the combinations bendamustine–lenalidomide–dexamethasone and bendamustine–bortezomib–dexamethasone for advanced stage multiple myeloma

Giuseppe MeleClinical Division of Haematology and BMT Unit; “Antonio Perrino” Hospital, Brindisi, ItalyCorrespondence[email protected]
,
Alessandro SpinaClinical Division of Haematology and BMT Unit; “Antonio Perrino” Hospital, Brindisi, Italy
,
Gianluca GuaragnaClinical Division of Haematology and BMT Unit; “Antonio Perrino” Hospital, Brindisi, Italy
,
Angela GiannottaClinical Division of Haematology and BMT Unit; “Antonio Perrino” Hospital, Brindisi, Italy
,
Angela MelpignanoClinical Division of Haematology and BMT Unit; “Antonio Perrino” Hospital, Brindisi, Italy
&
Gianni QuartaClinical Division of Haematology and BMT Unit; “Antonio Perrino” Hospital, Brindisi, Italy
Pages 1191-1193 | Received 01 Apr 2013, Accepted 23 Jun 2013, Published online: 13 Aug 2013

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Samantha Pozzi, Massimo Gentile, Stefano Sacchi, Raffaella Marcheselli, Alessandro Corso, Federica Cocito, Pellegrino Musto, Attilio Guarini, Carla Minoia, Iolanda Vincelli, Roberto Ria, Elena Rivolti, Giuseppe Mele, Alessia Bari, Carla Mazzone, Stefania Badiali, Luigi Marcheselli, Antonio Palumbo & Fortunato Morabito. (2017) Bendamustine, Low-dose dexamethasone, and lenalidomide (BdL) for the treatment of patients with relapsed/refractory multiple myeloma confirms very promising results in a phase I/II study. Leukemia & Lymphoma 58:3, pages 552-559.
Read now
Pellegrino Musto, Vincenzo Ludovico Fraticelli, Giovanna Mansueto, Emanuela Madonna, Andrea Nozza, Alessandro Andriani, Alberto Mussetti, Stelvio Ballanti, Velia Bongarzoni, Anna Baraldi, Francesca Patriarca, Donatella Vincelli, Antonietta Falcone, Daniele Derudas, Catello Califano, Renato Zambello, Giuseppe Mele, Alberto Fragasso, Luca Baldini & Sergio Storti. (2015) Bendamustine in relapsed/refractory multiple myeloma: the “real-life” side of the moon. Leukemia & Lymphoma 56:5, pages 1510-1513.
Read now
Morie A. Gertz. (2015) The role of bendamustine in the management of plasma cell myeloma. Leukemia & Lymphoma 56:5, pages 1195-1196.
Read now

Articles from other publishers (3)

Kristen P. Zeligs, Monica K. Neuman & Christina M. Annunziata. (2016) Molecular Pathways: The Balance between Cancer and the Immune System Challenges the Therapeutic Specificity of Targeting Nuclear Factor-κB Signaling for Cancer Treatment. Clinical Cancer Research 22:17, pages 4302-4308.
Crossref
Steve Schey, Sarah R. Brown, Avie-Lee Tillotson, Kwee Yong, Cathy Williams, Faith Davies, Gareth Morgan, Jamie Cavenagh, Gordon Cook, Mark Cook, Guillermo Orti, Curly Morris, Debbie Sherratt, Louise Flanagan, Walter Gregory & James Cavet. (2015) Bendamustine, thalidomide and dexamethasone combination therapy for relapsed/refractory myeloma patients: results of the MUK one randomized dose selection trial . British Journal of Haematology 170:3, pages 336-348.
Crossref
Bruce D. Cheson & Jeanette Crawford. (2015) A phase I study of bendamustine, lenalidomide and rituximab in relapsed and refractory lymphomas. British Journal of Haematology 169:4, pages 528-533.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.